Latest On New Frontier Health Corporation (NFC):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2020-11-26 20:57 EST | Financials | Company financials have been released. | Neutral |  |
| 2020-11-08 00:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 16:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-03 12:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-22 05:09 EST | Analyst Rating | The Analyst Target Price has increased from $12.48 to $12.49. | Buy | |
| 2020-10-21 09:08 EST | Analyst Rating | The Analyst Target Price has increased from $12.47 to $12.48. | Buy | |
| 2020-10-20 17:35 EST | Analyst Rating | The Analyst Target Price has increased from $12.4 to $12.47. | Buy | |
| 2020-10-17 05:09 EST | Analyst Rating | The Analyst Target Price has decreased from $12.42 to $12.4. | Neutral | |
| 2020-10-16 05:11 EST | Analyst Rating | The Analyst Target Price has increased from $12.38 to $12.42. | Buy | |
| 2020-10-15 05:13 EST | Analyst Rating | The Analyst Target Price has increased from $12.36 to $12.38. | Buy | |
| 2020-10-14 09:12 EST | Analyst Rating | The Analyst Target Price has decreased from $12.47 to $12.36. | Neutral | |
| 2020-10-13 05:21 EST | Analyst Rating | The Analyst Target Price has increased from $12.3 to $12.47. | Buy | |
| 2020-10-08 09:43 EST | Analyst Rating | The Analyst Target Price has increased from $12.28 to $12.3. | Buy | |
| 2020-10-07 09:29 EST | Analyst Rating | The Analyst Target Price has decreased from $12.3 to $12.28. | Neutral | |
| 2020-10-04 05:27 EST | Analyst Rating | The Analyst Target Price has increased from $12.28 to $12.3. | Buy | |
| 2020-10-03 09:32 EST | Analyst Rating | The Analyst Target Price has decreased from $12.31 to $12.28. | Neutral | |
| 2020-10-01 21:25 EST | Analyst Rating | The Analyst Target Price has increased from $12.27 to $12.31. | Buy | |
| 2020-10-01 09:31 EST | Analyst Rating | The Analyst Target Price has decreased from $12.28 to $12.27. | Neutral | |
| 2020-09-30 17:46 EST | Analyst Rating | The Analyst Target Price has increased from $12.27 to $12.28. | Buy | |
| 2020-09-29 05:14 EST | Analyst Rating | The Analyst Target Price has increased from $12.26 to $12.27. | Buy | |
| 2020-09-26 13:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 05:22 EST | Analyst Rating | The Analyst Target Price has decreased from $12.28 to $12.26. | Neutral | |
| 2020-09-25 17:16 EST | Analyst Rating | The Analyst Target Price has increased from $12.18 to $12.28. | Buy | |
| 2020-09-25 05:25 EST | Analyst Rating | The Analyst Target Price has decreased from $12.23 to $12.18. | Neutral | |
| 2020-09-24 05:16 EST | Analyst Rating | The Analyst Target Price has increased from $12.19 to $12.23. | Buy | |
| 2020-09-23 09:35 EST | Analyst Rating | The Analyst Target Price has decreased from $12.27 to $12.19. | Neutral | |
| 2020-09-22 17:31 EST | Analyst Rating | The Analyst Target Price has decreased from $12.28 to $12.27. | Neutral | |
| 2020-09-22 09:39 EST | Analyst Rating | The Analyst Target Price has decreased from $16.78 to $12.28. | Neutral | |
| 2020-09-21 09:42 EST | Analyst Rating | The Analyst Target Price has increased from $12.28 to $16.78. | Buy | |
| 2020-09-18 17:45 EST | Analyst Rating | The Analyst Target Price has decreased from $12.42 to $12.28. | Neutral | |
| 2020-09-18 05:43 EST | Analyst Rating | The Analyst Target Price has increased from $12.37 to $12.42. | Buy | |
| 2020-09-17 05:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 05:37 EST | Analyst Rating | The Analyst Target Price has increased from $12.32 to $12.37. | Buy | |
| 2020-09-16 05:11 EST | Analyst Rating | The Analyst Target Price has increased from $12.29 to $12.32. | Buy | |
| 2020-09-12 05:10 EST | Analyst Rating | The Analyst Target Price has increased from $12.28 to $12.29. | Buy | |
| 2020-09-11 17:22 EST | Analyst Rating | The Analyst Target Price has decreased from $12.29 to $12.28. | Neutral | |
| 2020-09-11 05:10 EST | Analyst Rating | The Analyst Target Price has increased from $12.28 to $12.29. | Buy | |
| 2020-09-10 05:08 EST | Analyst Rating | The Analyst Target Price has decreased from $12.31 to $12.28. | Neutral | |
| 2020-09-09 05:54 EST | Analyst Rating | The Analyst Target Price has increased from $12.29 to $12.31. | Buy | |
| 2020-09-08 01:16 EST | Analyst Rating | The Analyst Target Price has increased from $12.28 to $12.29. | Buy | |
| 2020-09-05 05:08 EST | Analyst Rating | The Analyst Target Price has decreased from $12.31 to $12.28. | Neutral | |
| 2020-09-04 21:17 EST | Analyst Rating | The Analyst Target Price has decreased from $12.4 to $12.31. | Neutral | |
| 2020-09-03 05:33 EST | Analyst Rating | The Analyst Target Price has increased from $12.36 to $12.4. | Buy | |
| 2020-09-02 05:11 EST | Analyst Rating | The Analyst Target Price has increased from $12.33 to $12.36. | Buy | |
| 2020-09-01 05:11 EST | Analyst Rating | The Analyst Target Price has increased from $12.29 to $12.33. | Buy | |
| 2020-08-31 13:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-29 05:07 EST | Analyst Rating | The Analyst Target Price has increased from $12.28 to $12.29. | Buy | |
| 2020-08-28 17:11 EST | Analyst Rating | The Analyst Target Price has decreased from $12.34 to $12.28. | Neutral | |
| 2020-08-28 05:08 EST | Analyst Rating | The Analyst Target Price has increased from $12.31 to $12.34. | Buy | |
| 2020-08-27 05:11 EST | Analyst Rating | The Analyst Target Price has increased from $12.3 to $12.31. | Buy | |
About New Frontier Health Corporation (NFC):
New Frontier Health Corporation provides healthcare services. It operates a network of hospital inpatient departments and integrated outpatient clinics, including satellite feeder clinics. The company's facilities include 24/7 emergency rooms, intensive care units, neonatal intensive care units, operating rooms, clinical laboratories, radiology, and blood banking services. It operates five hospitals and eight clinics in northern China; two hospitals and four clinics in eastern China; and two hospitals and two clinics in southern China. The company is based in Beijing, China.
General
- Name New Frontier Health Corporation
- Symbol NFC
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorFinancial
- IndustryClosed-End Fund - Debt
- Last Split Factor1:2
- Last Split Date2004-02-12
- Fiscal Year EndDecember
- IPO Date2018-07-27
- Web URLhttp://www.nfh.com.cn
View More
Valuation
- Forward PE 188.68
- Price/Sales (Trailing 12 Mt.) 3.27
- Price/Book (Most Recent Quarter) 0.88
- Enterprise Value Revenue 0.68
- Enterprise Value EBITDA 5.88
View More
Financials
- Most Recent Quarter 2020-06-30
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 409.08 million
- Analyst Target Price $12.49
- Book Value Per Share $0.12
View More
Share Statistics
- Shares Outstanding 28.75 million
- Shares Float 61.89 million
- % Held by Insiders 917%
- % Held by Institutions 40.41%
View More
Technicals
- Beta 0.12
- 52 Week High $9.85
- 52 Week Low $7.3
- 50 Day Moving Average 8.16
- 200 Day Moving Average 8.2
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
View More
New Frontier Health Corporation (NFC) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
New Frontier Health Corporation (NFC) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | N/A |
| Income Before Tax | N/A | -175.78 million | -127.27 million | -7.64 million | 244370.3 |
| Selling General Administrative | N/A | 306.45 million | 1.29 billion | 9.21 million | 7392.33 |
| Gross Profit | N/A | 355.45 million | 528.14 million | N/A | N/A |
| Ebit | N/A | 4.67 million | 41.22 million | -9.21 million | -7392.33 |
| Operating Income | N/A | -124.22 million | 58.55 million | -9.21 million | -7392.33 |
| Income Tax Expense | 6.94 million | N/A | N/A | N/A | N/A |
| Total Revenue | N/A | 430.94 million | 2.37 billion | N/A | N/A |
| Cost of Revenue | N/A | 75.49 million | 111.61 million | N/A | N/A |
| Total Other Income Expense Net | N/A | 20.39 million | -3.63 million | 1.58 million | 251762.63 |
| Net Income From Continuing Operations | N/A | -168.57 million | -195.69 million | -7.64 million | 244370.3 |
| Net Income Applicable to Common Shares | -73.81 million | N/A | N/A | -7.64 million | 244370.3 |
Cash Flow:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | -14.63 million | -341.77 million | -187 | N/A |
| Change to Liabilities | N/A | N/A | N/A | 50775 | -36215.25 |
| Total Cash Flow from Investing Activities | -112.61 million | N/A | N/A | N/A | N/A |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | N/A | N/A | -189.96 million | N/A | N/A |
| Change to Operating Activities | N/A | N/A | N/A | 8.66 million | 8632.31 |
| Change in Cash | N/A | -304.74 million | -207.16 million | -501369 | -34975.26 |
| Total Cash from Operating Activities | 386.56 million | -237.02 million | 324.57 million | -501369 | -34975.26 |
| Depreciation | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Investing Activities | -112.61 million | N/A | N/A | 187 | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | -476.77 million | N/A | N/A | N/A | N/A |
| Change to Net Income | 354.21 million | N/A | N/A | -1.58 million | -251762.63 |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A |
Balance Sheet:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | 5.96 billion | 6.24 billion | 291.78 million | 42.42 million |
| Total Stockholder Equity | N/A | 8 billion | 8.17 billion | 5 million | 729746.05 |
| Other Current Liabilities | N/A | N/A | N/A | 30000 | 1.01 million |
| Total Assets | N/A | 14.19 billion | 14.65 billion | 296.78 million | 43.15 million |
| Common Stock | 91000 | N/A | N/A | 1287 | 176.74 |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | -499.6 million | -425.79 million | -265.62 million | -2.64 million | 729569.3 |
| Other Liabilities | 751.01 million | N/A | N/A | 282.81 million | 41.38 million |
| Other Assets | 152.15 million | N/A | N/A | 295.48 million | 42.89 million |
| Cash | N/A | 1.06 billion | 1.35 billion | 1.24 million | 254133.43 |
| Total Current Liabilities | N/A | 1.51 billion | 1.76 billion | 8.97 million | 1.04 million |
| Other Stockholder Equity | -3.32 million | N/A | N/A | N/A | N/A |
| Property, Plant & Equipment | 3.56 billion | N/A | N/A | N/A | N/A |
| Total Current Assets | N/A | 1.73 billion | 2.11 billion | 1.3 million | 254637.39 |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | -676.47 million | N/A | N/A | 5 million | 729746.05 |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | 2.06 billion | 2.06 billion | N/A | N/A |
| Inventory | N/A | 63.22 million | 56.59 million | N/A | N/A |
| Accounts Payable | N/A | 104.61 million | 99.08 million | 155901 | 15343.05 |
New Frontier Health Corporation (NFC) Chart:
New Frontier Health Corporation (NFC) News:
Below you will find a list of latest news for New Frontier Health Corporation (NFC) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
New Frontier Health Corporation (NFC) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
New Frontier Health Corporation (NFC) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-05-27 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1737422/000110465920066088/0001104659-20-066088-index.htm |
| 2018-05-24 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1737422/000000000018016127/0000000000-18-016127-index.htm |
| 2018-06-19 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1737422/000000000018018862/0000000000-18-018862-index.htm |
| 2018-06-21 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1737422/000000000018019185/0000000000-18-019185-index.htm |
| 2019-10-07 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1737422/000000000019014348/0000000000-19-014348-index.htm |
| 2019-11-07 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1737422/000000000019015314/0000000000-19-015314-index.htm |
| 2019-11-20 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1737422/000000000019015677/0000000000-19-015677-index.htm |
| 2019-11-25 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1737422/000000000019015836/0000000000-19-015836-index.htm |
| 2020-01-28 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1737422/000000000020000737/0000000000-20-000737-index.htm |
| 2018-06-27 | CERT | Certification | https://www.sec.gov/Archives/edgar/data/1737422/000087666118000746/0000876661-18-000746-index.htm |
| 2019-12-19 | 25-NSE | Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or ret | https://www.sec.gov/Archives/edgar/data/1737422/000087666119001287/0000876661-19-001287-index.htm |
| 2020-01-02 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1737422/000090445420000002/0000904454-20-000002-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737422/000108514619000786/0001085146-19-000786-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737422/000108514620000634/0001085146-20-000634-index.htm |
| 2019-10-25 | PRER14A | Preliminary Proxy Soliciting materials | https://www.sec.gov/Archives/edgar/data/1737422/000110465919056358/0001104659-19-056358-index.htm |
| 2019-10-25 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1737422/000110465919056518/0001104659-19-056518-index.htm |
| 2019-10-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737422/000110465919056539/0001104659-19-056539-index.htm |
| 2019-10-25 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1737422/000110465919056541/0001104659-19-056541-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737422/000110465919060511/0001104659-19-060511-index.htm |
| 2019-11-06 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1737422/000110465919060514/0001104659-19-060514-index.htm |
| 2019-11-12 | PRER14A | Preliminary Proxy Soliciting materials | https://www.sec.gov/Archives/edgar/data/1737422/000110465919062664/0001104659-19-062664-index.htm |
| 2019-11-12 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1737422/000110465919062758/0001104659-19-062758-index.htm |
| 2019-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1737422/000110465919064082/0001104659-19-064082-index.htm |
| 2019-11-22 | PRER14A | Preliminary Proxy Soliciting materials | https://www.sec.gov/Archives/edgar/data/1737422/000110465919066661/0001104659-19-066661-index.htm |
| 2019-11-22 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1737422/000110465919066702/0001104659-19-066702-index.htm |
| 2019-11-29 | DEFM14A | Definitive proxy statement relating to merger or acquisition | https://www.sec.gov/Archives/edgar/data/1737422/000110465919068418/0001104659-19-068418-index.htm |
| 2019-12-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737422/000110465919068950/0001104659-19-068950-index.htm |
| 2019-12-02 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1737422/000110465919068953/0001104659-19-068953-index.htm |
| 2019-12-06 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1737422/000110465919070365/0001104659-19-070365-index.htm |
| 2019-12-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737422/000110465919070367/0001104659-19-070367-index.htm |
| 2019-12-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737422/000110465919072108/0001104659-19-072108-index.htm |
| 2019-12-20 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1737422/000110465919074961/0001104659-19-074961-index.htm |
| 2019-12-20 | 8-A12B/A | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1737422/000110465919074972/0001104659-19-074972-index.htm |
| 2019-12-26 | 20FR12B | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1737422/000110465919076170/0001104659-19-076170-index.htm |
| 2019-12-26 | F-3 | Registration statement by foreign private issuers | https://www.sec.gov/Archives/edgar/data/1737422/000110465919076214/0001104659-19-076214-index.htm |
| 2019-12-30 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1737422/000110465919076768/0001104659-19-076768-index.htm |
| 2019-12-30 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1737422/000110465919076842/0001104659-19-076842-index.htm |
| 2020-01-24 | F-1 | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/1737422/000110465920006766/0001104659-20-006766-index.htm |
| 2020-01-28 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1737422/000110465920007504/0001104659-20-007504-index.htm |
| 2020-02-19 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1737422/000110465920022803/0001104659-20-022803-index.htm |
| 2020-03-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1737422/000110465920038546/0001104659-20-038546-index.htm |
| 2020-03-31 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1737422/000110465920041224/0001104659-20-041224-index.htm |
| 2020-03-31 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1737422/000110465920041227/0001104659-20-041227-index.htm |
| 2020-05-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1737422/000110465920066087/0001104659-20-066087-index.htm |
| 2020-05-27 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1737422/000110465920066088/0001104659-20-066088-index.htm |
| 2020-08-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1737422/000110465920089371/0001104659-20-089371-index.htm |
| 2020-08-17 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1737422/000110465920096132/0001104659-20-096132-index.htm |
| 2020-08-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1737422/000110465920099146/0001104659-20-099146-index.htm |
| 2020-08-27 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1737422/000110465920099302/0001104659-20-099302-index.htm |
| 2018-04-27 | DRS | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1737422/000114420418023248/0001144204-18-023248-index.htm |
| 2018-06-04 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1737422/000114420418032700/0001144204-18-032700-index.htm |
| 2018-06-04 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1737422/000114420418032703/0001144204-18-032703-index.htm |
| 2018-06-14 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1737422/000114420418034124/0001144204-18-034124-index.htm |
| 2018-06-20 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1737422/000114420418034913/0001144204-18-034913-index.htm |
| 2018-06-20 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1737422/000114420418034914/0001144204-18-034914-index.htm |
| 2018-06-22 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1737422/000114420418035263/0001144204-18-035263-index.htm |
| 2018-06-22 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1737422/000114420418035266/0001144204-18-035266-index.htm |
| 2018-06-25 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1737422/000114420418035639/0001144204-18-035639-index.htm |
| 2018-06-25 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1737422/000114420418035640/0001144204-18-035640-index.htm |
| 2018-06-26 | 8-A12B | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1737422/000114420418035814/0001144204-18-035814-index.htm |
| 2018-06-27 | S-1MEF | Registration adding securities to prior Form S-1 registration [Rule 462(b)] | https://www.sec.gov/Archives/edgar/data/1737422/000114420418036167/0001144204-18-036167-index.htm |
| 2018-06-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737422/000114420418036183/0001144204-18-036183-index.htm |
| 2018-06-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737422/000114420418036186/0001144204-18-036186-index.htm |
| 2018-06-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737422/000114420418036187/0001144204-18-036187-index.htm |
| 2018-06-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737422/000114420418036188/0001144204-18-036188-index.htm |
| 2018-06-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737422/000114420418036189/0001144204-18-036189-index.htm |
| 2018-06-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737422/000114420418036190/0001144204-18-036190-index.htm |
| 2018-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737422/000114420418036495/0001144204-18-036495-index.htm |
| 2018-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737422/000114420418036497/0001144204-18-036497-index.htm |
| 2018-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737422/000114420418036499/0001144204-18-036499-index.htm |
| 2018-06-29 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1737422/000114420418036661/0001144204-18-036661-index.htm |
| 2018-06-29 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737422/000114420418036689/0001144204-18-036689-index.htm |
| 2018-07-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737422/000114420418037276/0001144204-18-037276-index.htm |
| 2018-07-09 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1737422/000114420418037700/0001144204-18-037700-index.htm |
| 2018-07-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737422/000114420418037886/0001144204-18-037886-index.htm |
| 2018-07-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737422/000114420418039601/0001144204-18-039601-index.htm |
| 2018-08-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1737422/000114420418043821/0001144204-18-043821-index.htm |
| 2018-11-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1737422/000114420418059278/0001144204-18-059278-index.htm |
| 2019-04-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1737422/000114420419017454/0001144204-19-017454-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737422/000114420419017550/0001144204-19-017550-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737422/000114420419017551/0001144204-19-017551-index.htm |
| 2019-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1737422/000114420419026403/0001144204-19-026403-index.htm |
| 2019-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737422/000114420419036554/0001144204-19-036554-index.htm |
| 2019-07-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1737422/000114420419036562/0001144204-19-036562-index.htm |
| 2019-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737422/000114420419036565/0001144204-19-036565-index.htm |
| 2019-07-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1737422/000114420419036566/0001144204-19-036566-index.htm |
| 2019-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737422/000114420419037123/0001144204-19-037123-index.htm |
| 2019-08-01 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1737422/000114420419037125/0001144204-19-037125-index.htm |
| 2019-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1737422/000114420419039894/0001144204-19-039894-index.htm |
| 2019-09-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737422/000114420419043890/0001144204-19-043890-index.htm |
| 2019-09-09 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1737422/000114420419043892/0001144204-19-043892-index.htm |
| 2019-09-11 | PREM14A | Preliminary proxy statements relating to merger or acquisition | https://www.sec.gov/Archives/edgar/data/1737422/000114420419044280/0001144204-19-044280-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737422/000142284820000035/0001422848-20-000035-index.htm |
| 2018-06-27 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1737422/999999999518001645/9999999995-18-001645-index.htm |
| 2020-01-28 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1737422/999999999520000178/9999999995-20-000178-index.htm |
| 2020-04-08 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1737422/999999999520000707/9999999995-20-000707-index.htm |